Tiziana Life Sciences Ltd (TLSA) stock
TLSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.61−0.01 (-1.61%)
Close on Nov 12, 2026Market cap $73.51MP/E –Yield –
Tiziana Life Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Tiziana Life Sciences's enterprise value was $68.14M on Nov 10, 2026, against $188.29M a year earlier. Over the last 5 years it ranged from $14.94M to $262.96M, with a median of $70.16M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $68.14M | -56.1% |
| 2025 | Dec 31, 2025 | $155.22M | +121.2% |
| 2024 | Dec 31, 2024 | $70.16M | +81.1% |
| 2023 | Dec 29, 2023 | $38.73M | +133.7% |
| 2022 | Dec 30, 2022 | $16.57M | -39.9% |
| 2021 | Dec 31, 2021 | $27.59M | -85.9% |
| 2020 | Dec 31, 2020 | $196.36M | -42.1% |
| 2019 | Dec 31, 2019 | $339.08M | -14.4% |
| 2018 | Dec 31, 2018 | $396.29M | – |
See a number that looks wrong?